Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease

OBJECTIVES: To compare the risk of non‐skin cancer in LRRK2 mutation carriers and individuals with idiopathic Parkinson's disease (iPD), explore the age at which LRRK2 mutation carriers have cancer compared to iPD subjects, and clarify whether certain cancers are more closely associated with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Warø, Bjørg Johanne, Aasly, Jan O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853627/
https://www.ncbi.nlm.nih.gov/pubmed/29568677
http://dx.doi.org/10.1002/brb3.858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853627/
https://www.ncbi.nlm.nih.gov/pubmed/29568677
http://dx.doi.org/10.1002/brb3.858

Ejemplares similares